ACLIDINIUM BROMIDE
| Brand name | TUDORZA PRESSAIR |
|---|---|
| Active ingredient | ACLIDINIUM BROMIDE |
| Strength | 0.4MG/INH |
| Dosage form | POWDER, METERED |
| Route | INHALATION |
| Modality | Small molecule |
| FDA approval | July 2012 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 10085974 | March 2029 | product |
| 11000517 | March 2029 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.